Patterns of Medication Discontinuation and Their Impact on Accessibility in Brazil (2014–2024)
By
Raphaella Oliveira Martins de Lima
Esther Ramos Silva
Isabel C. M. Emmerick
Danielle Maria de Souza Serio dos Santos
Isabella Piassi Dias Godói
Ana Cristina Viana Campos
Luisa Arueira Chaves
August 22, 2026
Clinical Scorecard: Patterns of Medication Discontinuation and Their Impact on Accessibility in Brazil (2014–2024)
At a Glance
Category Detail
Condition Medication Discontinuation Key Mechanisms Supply and demand perspectives affecting availability of essential medicines. Target Population General population in Brazil requiring access to essential medicines. Care Setting Pharmaceutical supply chain management.
Key Highlights
Drug shortages are a global issue impacting health systems and patient care. Brazil relies on a drug discontinuation panel to manage medicine interruptions. The study examines patterns of medicine discontinuation from 2014 to 2024. Discontinuation reasons include increased demand and manufacturing issues. Monitoring discontinuations may help prevent shortages in Brazil. Guideline-Based Recommendations
Diagnosis
Monitor and analyze notifications of medicine discontinuation. Management
Implement integrated prevention and response policies across the supply chain. Monitoring & Follow-up
Utilize the drug discontinuation panel for ongoing assessment of medicine availability. Risks
Inadequate supply of essential medicines can lead to interruptions in care and patient safety risks. Patient & Prescribing Data
Patients in Brazil dependent on essential medicines.
Access to essential medicines is a right that must be ensured by the State.
Clinical Best Practices
Adopt proactive surveillance mechanisms for drug shortages. Establish early-warning systems for potential medicine discontinuations. Encourage mandatory notification of production disruptions. Related Resources & Content
